EVOK
Price
$2.69
Change
-$0.14 (-4.95%)
Updated
Jun 26, 04:01 PM (EDT)
Capitalization
5.17M
SBFM
Price
$1.46
Change
+$0.05 (+3.55%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
6.02M
34 days until earnings call
Interact to see
Advertisement

EVOK vs SBFM

Header iconEVOK vs SBFM Comparison
Open Charts EVOK vs SBFMBanner chart's image
Evoke Pharma
Price$2.69
Change-$0.14 (-4.95%)
Volume$100
Capitalization5.17M
Sunshine Biopharma
Price$1.46
Change+$0.05 (+3.55%)
Volume$100
Capitalization6.02M
EVOK vs SBFM Comparison Chart in %
Loading...
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EVOK vs. SBFM commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVOK is a Buy and SBFM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (EVOK: $2.83 vs. SBFM: $1.41)
Brand notoriety: EVOK and SBFM are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: EVOK: 37% vs. SBFM: 35%
Market capitalization -- EVOK: $5.17M vs. SBFM: $6.02M
EVOK [@Pharmaceuticals: Other] is valued at $5.17M. SBFM’s [@Pharmaceuticals: Other] market capitalization is $6.02M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.78B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EVOK’s FA Score shows that 0 FA rating(s) are green whileSBFM’s FA Score has 0 green FA rating(s).

  • EVOK’s FA Score: 0 green, 5 red.
  • SBFM’s FA Score: 0 green, 5 red.
According to our system of comparison, SBFM is a better buy in the long-term than EVOK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EVOK’s TA Score shows that 4 TA indicator(s) are bullish while SBFM’s TA Score has 4 bullish TA indicator(s).

  • EVOK’s TA Score: 4 bullish, 6 bearish.
  • SBFM’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both EVOK and SBFM are a bad buy in the short-term.

Price Growth

EVOK (@Pharmaceuticals: Other) experienced а +3.82% price change this week, while SBFM (@Pharmaceuticals: Other) price change was -4.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.82%. For the same industry, the average monthly price growth was +13.89%, and the average quarterly price growth was +90.97%.

Reported Earning Dates

EVOK is expected to report earnings on May 13, 2025.

SBFM is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.82% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBFM($6.02M) has a higher market cap than EVOK($5.17M). EVOK YTD gains are higher at: -35.921 vs. SBFM (-53.000). EVOK has higher annual earnings (EBITDA): -7.29M vs. SBFM (-26.1M). SBFM has more cash in the bank: 18.8M vs. EVOK (4.74M). SBFM has less debt than EVOK: SBFM (674K) vs EVOK (5M). SBFM has higher revenues than EVOK: SBFM (20.4M) vs EVOK (5.18M).
EVOKSBFMEVOK / SBFM
Capitalization5.17M6.02M86%
EBITDA-7.29M-26.1M28%
Gain YTD-35.921-53.00068%
P/E RatioN/A0.88-
Revenue5.18M20.4M25%
Total Cash4.74M18.8M25%
Total Debt5M674K742%
FUNDAMENTALS RATINGS
EVOK vs SBFM: Fundamental Ratings
EVOK
SBFM
OUTLOOK RATING
1..100
5364
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
9165
P/E GROWTH RATING
1..100
7885
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBFM's Valuation (37) in the null industry is in the same range as EVOK (41) in the Pharmaceuticals Other industry. This means that SBFM’s stock grew similarly to EVOK’s over the last 12 months.

SBFM's Profit vs Risk Rating (100) in the null industry is in the same range as EVOK (100) in the Pharmaceuticals Other industry. This means that SBFM’s stock grew similarly to EVOK’s over the last 12 months.

SBFM's SMR Rating (94) in the null industry is in the same range as EVOK (98) in the Pharmaceuticals Other industry. This means that SBFM’s stock grew similarly to EVOK’s over the last 12 months.

SBFM's Price Growth Rating (65) in the null industry is in the same range as EVOK (91) in the Pharmaceuticals Other industry. This means that SBFM’s stock grew similarly to EVOK’s over the last 12 months.

EVOK's P/E Growth Rating (78) in the Pharmaceuticals Other industry is in the same range as SBFM (85) in the null industry. This means that EVOK’s stock grew similarly to SBFM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EVOKSBFM
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
EVOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MIR21.501.24
+6.12%
Mirion Technologies
IFBD1.090.06
+5.78%
Infobird Co Ltd
NPKI8.50-0.13
-1.51%
NPK International Inc
CPB31.18-0.99
-3.08%
The Campbell's Company
VXRT0.54-0.02
-3.93%
Vaxart

EVOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, EVOK has been loosely correlated with RDHL. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EVOK jumps, then RDHL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVOK
1D Price
Change %
EVOK100%
+2.62%
RDHL - EVOK
33%
Loosely correlated
-3.61%
NBIX - EVOK
28%
Poorly correlated
-0.31%
EOLS - EVOK
26%
Poorly correlated
-5.41%
EVO - EVOK
24%
Poorly correlated
+1.96%
PRFX - EVOK
24%
Poorly correlated
-12.48%
More

SBFM and

Correlation & Price change

A.I.dvisor tells us that SBFM and TLRY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and TLRY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-5.37%
TLRY - SBFM
24%
Poorly correlated
+3.14%
TXMD - SBFM
22%
Poorly correlated
+0.85%
EVOK - SBFM
22%
Poorly correlated
+2.62%
SUPN - SBFM
22%
Poorly correlated
-1.36%
AKAN - SBFM
22%
Poorly correlated
+18.38%
More